CBT for fear of cancer returning in BRCA1/2 women
Part of Cancer clinical trials.
This trial tests if cognitive behavioral therapy can reduce fear of cancer recurrence in women with BRCA1/2 mutations who have finished treatment for breast or ovarian cancer. It aims to help you cope with worries about cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have completed primary treatment (surgery, chemo, or radiation) for breast or ovarian cancer.
- You know you carry a BRCA1 or BRCA2 gene mutation that increases cancer risk.
- You have a significant fear of cancer returning, as measured by a standard questionnaire.
- You are at least 18 years old.
- You can read, understand, and express yourself in French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a program led by a clinician (like a doctor or nurse) to help people who are worried about their cancer returning. It's for people who recently finished treatment for breast, ovarian, prostate, or lung cancer.
This study compares two talking therapies to help reduce the fear that cancer might come back. It is for cancer survivors and their spouses or partners, and aims to find which approach works better for both.
This study tests a therapy program designed to help parents who worry about their child's cancer coming back. It aims to reduce that fear and see if parents find the program helpful and practical.
This trial tests a program to help Chinese-speaking cancer survivors manage their fear of cancer coming back. You may join if you have worries about recurrence but at a level that is not severe.
This program helps people who have finished treatment for breast, gynecological, or colorectal cancer manage fears about their cancer coming back. It offers screening and support to address those worries.
This study tests a web-based program designed to help breast cancer survivors manage fears that their cancer might return. It compares the program to usual care to see if it reduces worry and improves quality of life.
Hear when a new BRCA2 Mutation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.